| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 10/21/2004 | US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine |
| 10/20/2004 | EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 10/20/2004 | CN1537641A Sodium hyaluronate anti-adhesion film, and its prepn. method |
| 10/13/2004 | EP1466017A2 Tissue rejection |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465887A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
| 10/13/2004 | EP1465676A1 Film-forming compositions and methods |
| 10/13/2004 | EP1161245B1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800298 Biological lubricant composition and method of applying lubricant composition |
| 09/30/2004 | US20040192643 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| 09/29/2004 | EP1461122A2 Treatment of genitourinary tract disorders |
| 09/29/2004 | EP1059913B1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/29/2004 | EP1001790B1 Compositions for lubricating and separating tissues and biological membranes |
| 09/23/2004 | WO2004081042A2 Identification of pain-relevant genes of a snsr family (specific sensory neurone receptors) |
| 09/23/2004 | WO2004035011A3 Botulinum toxin dental therapies and procedures |
| 09/23/2004 | DE10310758A1 Identifying compounds that modulate sensory neuron specific receptors, useful for treating pain, also nucleic acid encoding the receptors, related proteins and their modulators |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458425A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 09/16/2004 | WO2004078210A1 Preventive for adhesion following abdominal surgery |
| 09/16/2004 | WO2003105666A3 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | DE20320528U1 Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten New crystal forms of ondansetron and pharmaceutical compositions containing the new forms |
| 09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 09/15/2004 | CN1529605A Method employing and compositions containing defined oxidized phospholipids for preventing and breating atherosclerosis |
| 09/15/2004 | CN1529604A Drug for treatment of osteonecrosis and for management of patients at risk of evelopment osteonecrosis |
| 09/15/2004 | CN1166677C Thiophene A2A receptor aganoists |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/10/2004 | WO2004060261A3 Novel factor viia inhibiting compounds |
| 09/10/2004 | WO2004035070A9 Induction of gene expression using a high concentration sugar mixture |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | DE10004790B4 Method for producing sewn or embroidered three-dimensional textile structure utilized for e.g. table cloth, involves connecting points on lattice structure with threads to form thread arrangement under which lattice structure is not visible |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 09/08/2004 | EP1126870B1 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/01/2004 | EP1451193A1 Podophyllotoxins as antiproliferative agents |
| 09/01/2004 | EP1450781A1 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1448222A1 Biphasic mixtures of glp-1 and insulin |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 08/25/2004 | CN1163125C Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 08/19/2004 | WO2004069276A1 Drug for preventing, regulating or treating adhesion |
| 08/18/2004 | EP1446150A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/17/2004 | US6778854 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1443945A1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/04/2004 | CN1160115C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 08/03/2004 | US6770619 Lung surfactant compositions with dynamic swelling behavior |
| 07/29/2004 | WO2003093313A3 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 07/28/2004 | EP1322593B1 O-substituted 6-methyl-tramadol derivatives |
| 07/28/2004 | EP1322592B1 Substituted 1-aminobutan-3-ol derivatives |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/27/2004 | US6767555 A cyclosporin-containing composition in the form of a capsule consists of a polyoxyethylene sorbitan fatty acid ester, a reaction product of a natural or hydrogenated castor oil, ethylene oxide, a sorbitan fatty ester, and ethanol |
| 07/22/2004 | WO2004060261A2 Novel factor viia inhibiting compounds |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2514477A1 Novel factor viia inhibiting compounds |
| 07/21/2004 | EP1438976A1 Polyfunctional biocompatible hydrogel and method for the production thereof |
| 07/21/2004 | EP1438022A1 Drug release system for controlled therapy |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137179 Synechia inhibitory material |
| 07/15/2004 | US20040137034 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | DE10300049A1 Neue Verbindungen, die Faktor VIIa inhibieren Novel compounds which inhibit factor VIIa |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | CN1511544A Traditional Chinese medicine compound preparation for preventing and treating intestinal adhesion and preparing method |
| 07/08/2004 | WO2004056181A1 Organ preconditioning, arrest, protection, preservation and recovery (2) |
| 07/08/2004 | WO2004056180A1 Organ preconditioning, arrest, protection, preservation and recovery (1) |
| 07/08/2004 | DE10257360A1 Gastro-intestinal verabreichbare Formulierung und deren Verwendung Gastro-intestinal administrable formulation and their use |
| 07/08/2004 | CA2551169A1 Organ preconditioning, arrest, protection preservation and recovery (2) |
| 07/01/2004 | US20040127537 Stable liquid parenteral parecoxib formulation |
| 07/01/2004 | US20040126420 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 06/30/2004 | EP1432427A1 Composition of hypochlorous acid and its applications |
| 06/30/2004 | CN1509170A Method for inhibiting adhesion formation |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/24/2004 | WO2004052352A1 Formulation, which can be administered gastrointestinally, containing green tea extract and an no donor |
| 06/24/2004 | US20040121446 Induction of gene expression using a high concentration sugar mixture |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | CN1507358A Carrier with solid fibrinogen and solid thrombin |